めまい治療の世界市場レポート 2025年

めまい治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.7％で21億米ドルに成長します。予測期間の成長は、臨床試験数の増加、新薬の出現、政府のイニシアチブの高まり、医薬品の利用可能性の拡大、脳幹障害の有病率の増加などに起因しています。この期間の主な動向としては、新規のめまい関連治療薬の開発、遠隔医療サービスの拡大、機器ベースの治療の進展、技術革新、戦略的提携などが挙げられます。

スポーツ関連傷害の増加傾向は、めまい治療市場の成長を大きく促進しています。スポーツ関連傷害は、スポーツ活動や肉体的な運動中に負わされるもので、衝撃の大きいスポーツへの参加の増加、激しいトレーニングレジメン、不十分な傷害予防対策のために一般的になっています。このような怪我は、しばしば平衡感覚障害やめまいを引き起こし、薬物療法、前庭リハビリテーション療法、生活習慣の改善を含むめまい治療が必要となります。このような治療により、アスリートはより早く回復し、協調性を取り戻し、安全にスポーツ活動に復帰することができます。米国道路交通安全局によると、2024年7月、2022年のペダル自転車による死亡事故は13％増加し、2021年の976件から1,105件に増加しました。さらに、2022年に負傷した自転車利用者は4万6,195人と推定され、2021年の4万1,615人から11％増加しました。このような負傷の急増は、効果的なめまい治療に対する需要の高まりを裏付けています。

めまい治療、特にデジタルヘルスソリューションの技術的進歩は、市場拡大をさらに促進しています。デジタル・ヘルス・ソリューションは、健康管理、診断、治療のアドヒアランスを向上させるためにテクノロジー主導のツールを活用します。2023年8月、アボット・ラボラトリーズはインドでVertigo Coachアプリを発表し、個人のめまい管理を支援するデジタルプラットフォームを提供しました。このアプリは、リソース、エクササイズ、ライフスタイルの推奨、服薬リマインダーを提供し、患者と医師のコミュニケーションを強化し、治療計画のアドヒアランスを向上させます。このような技術革新は、より身近で効果的なめまい管理に貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界めまい治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のめまい治療市場：成長率分析
• 世界のめまい治療市場の実績：規模と成長, 2019-2024
• 世界のめまい治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界めまい治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のめまい治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 末梢性めまい
• 中央めまい
• 世界のめまい治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 手術
• 治療
• 世界のめまい治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 非経口
• その他の投与経路
• 世界のめまい治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界のめまい治療市場末梢性めまいの分類（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 良性発作性頭位めまい症（BPPV）
• メニエール病
• 前庭神経炎
• 迷路炎
• 世界のめまい治療市場中枢性めまいの分類（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前庭性片頭痛
• 脳卒中に伴うめまい
• 多発性硬化症関連めまい
• 脳腫瘍関連のめまい

第7章 地域別・国別分析

• 世界のめまい治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のめまい治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• めまい治療市場：競合情勢
• めまい治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lupin Ltd.
• Vertigenius
• Kracie Holdings Ltd.
• Biologische Heilmittel Heel GmbH
• Interacoustics A/S.
• AdvaCare Pharma
• AuroPharma Inc.
• Biofield Pharma Pvt Ltd.
• Sound Pharmaceuticals Inc.
• Otolith Labs Inc.
• Ear Technology Corporation
• NeuroEquilibrium Diagnostic Systems Pvt Ltd.
• Vestibular First
• Natus Medical Incorporated
• Ronish Bioceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• めまい治療市場2029：新たな機会を提供する国
• めまい治療市場2029：新たな機会を提供するセグメント
• めまい治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vertigo treatment involves medical interventions designed to alleviate symptoms such as dizziness and balance issues. It includes medications, physical therapy, and lifestyle modifications to manage the underlying causes, helping to improve balance, reduce dizziness, and prevent vertigo episodes. This treatment is used for conditions such as benign paroxysmal positional vertigo (BPPV), vestibular disorders, and other related conditions.

The main types of vertigo treatment are peripheral vertigo and central vertigo. Peripheral vertigo results from issues in the inner ear or the vestibular nerve, which connects the inner ear to the brain. Treatment options include medication, surgery, and therapy, administered through oral, topical, parenteral, and other routes. These treatments are utilized by various end users, including hospitals, clinics, and other healthcare facilities.

The vertigo treatment market research report is one of a series of new reports from The Business Research Company that provides vertigo treatment market statistics, including vertigo treatment industry global market size, regional shares, competitors with a vertigo treatment market share, detailed vertigo treatment market segments, market trends and opportunities, and any further data you may need to thrive in the vertigo treatment industry. This vertigo treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vertigo treatment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to the increasing geriatric population, rising healthcare expenditure, growing investments in research and development, a higher incidence of vertigo cases, and greater awareness of ear-related conditions.

The vertigo treatment market size is expected to see strong growth in the next few years. It will grow to $2.10 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the increasing number of clinical trials, the emergence of new drugs, rising government initiatives, greater availability of medications, and a growing prevalence of brain stem disorders. Key trends during this period include the development of novel vertigo-related therapeutics, the expansion of telehealth services, advancements in device-based therapies, technological innovations, and strategic collaborations.

The rising prevalence of sports-related injuries is significantly driving the growth of the vertigo treatment market. Sports-related injuries, sustained during athletic activities or physical exertion, have become more common due to increased participation in high-impact sports, intense training regimens, and inadequate injury prevention measures. These injuries often lead to balance disorders and dizziness, necessitating vertigo treatments that include medications, vestibular rehabilitation therapy, and lifestyle modifications. Such treatments help athletes recover faster, regain coordination, and safely return to sports activities. According to the National Highway Traffic Safety Administration, in July 2024, there was a 13% increase in pedal cyclist fatalities in 2022, rising from 976 in 2021 to 1,105. Additionally, an estimated 46,195 pedal cyclists sustained injuries in 2022, reflecting an 11% rise from 41,615 in 2021. This surge in injuries underscores the growing demand for effective vertigo treatments.

Technological advancements in vertigo treatment, particularly through digital health solutions, are further driving market expansion. Digital health solutions leverage technology-driven tools to improve health management, diagnosis, and treatment adherence. In August 2023, Abbott Laboratories introduced the Vertigo Coach app in India, offering a digital platform to help individuals manage vertigo. The app provides resources, exercises, lifestyle recommendations, and medication reminders, enhancing patient-physician communication and improving adherence to treatment plans. Such innovations contribute to more accessible and effective vertigo management.

In April 2023, Marksans Pharma acquired an Indian manufacturing facility from Teva Pharmaceutical Industries, expanding its production capacity from 8 billion units per year. This acquisition enables the company to produce a broader range of pharmaceutical products, including tablets, capsules, ointments, and liquids, further strengthening its presence in the vertigo treatment market. By increasing manufacturing capabilities, Marksans Pharma aims to meet the rising demand for effective vertigo treatments and expand its market share.

Major players in the vertigo treatment market are Pfizer Inc., Abbott Laboratories, Medtronic Plc, Boston Scientific Corp., Eisai Co. Ltd., Lupin Ltd., Vertigenius, Kracie Holdings Ltd., Biologische Heilmittel Heel GmbH, Interacoustics A/S., AdvaCare Pharma, AuroPharma Inc., Biofield Pharma Pvt Ltd., Sound Pharmaceuticals Inc., Otolith Labs Inc., Ear Technology Corporation, NeuroEquilibrium Diagnostic Systems Pvt Ltd., Vestibular First, Natus Medical Incorporated, Ronish Bioceuticals.

North America was the largest region in the vertigo treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vertigo treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vertigo treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vertigo treatment market consists of revenues earned by entities by providing services such as diagnostic assessments, vestibular rehabilitation therapy, telemedicine consultations and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The vertigo treatment market also includes sales of anti-vertigo medications, anti-nausea medications, vestibular rehabilitation devices, wearable balance aids, diagnostic equipment and balance training apps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vertigo Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vertigo treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vertigo treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vertigo treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Peripheral Vertigo; Central Vertigo
• 2) By Treatment: Medication; Surgery; Therapy
• 3) By Route Of Administration: Oral; Topical; Parenteral; Other Routes Of Administration
• 4) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Peripheral Vertigo: Benign Paroxysmal Positional Vertigo (BPPV); Meniere's Disease; Vestibular Neuritis; Labyrinthitis
• 2) By Central Vertigo: Vestibular Migraine; Stroke-Related Vertigo; Multiple Sclerosis-Associated Vertigo; Brain Tumor-Related Vertigo
• Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Medtronic Plc; Boston Scientific Corp.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vertigo Treatment Market Characteristics

3. Vertigo Treatment Market Trends And Strategies

4. Vertigo Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vertigo Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vertigo Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vertigo Treatment Market Growth Rate Analysis
• 5.4. Global Vertigo Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vertigo Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vertigo Treatment Total Addressable Market (TAM)

6. Vertigo Treatment Market Segmentation

• 6.1. Global Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Vertigo
• Central Vertigo
• 6.2. Global Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Therapy
• 6.3. Global Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Parenteral
• Other Routes Of Administration
• 6.4. Global Vertigo Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.5. Global Vertigo Treatment Market, Sub-Segmentation Of Peripheral Vertigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benign Paroxysmal Positional Vertigo (BPPV)
• Meniere's Disease
• Vestibular Neuritis
• Labyrinthitis
• 6.6. Global Vertigo Treatment Market, Sub-Segmentation Of Central Vertigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vestibular Migraine
• Stroke-Related Vertigo
• Multiple Sclerosis-Associated Vertigo
• Brain Tumor-Related Vertigo

7. Vertigo Treatment Market Regional And Country Analysis

• 7.1. Global Vertigo Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vertigo Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vertigo Treatment Market

• 8.1. Asia-Pacific Vertigo Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vertigo Treatment Market

• 9.1. China Vertigo Treatment Market Overview
• 9.2. China Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vertigo Treatment Market

• 10.1. India Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vertigo Treatment Market

• 11.1. Japan Vertigo Treatment Market Overview
• 11.2. Japan Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vertigo Treatment Market

• 12.1. Australia Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vertigo Treatment Market

• 13.1. Indonesia Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vertigo Treatment Market

• 14.1. South Korea Vertigo Treatment Market Overview
• 14.2. South Korea Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vertigo Treatment Market

• 15.1. Western Europe Vertigo Treatment Market Overview
• 15.2. Western Europe Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vertigo Treatment Market

• 16.1. UK Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vertigo Treatment Market

• 17.1. Germany Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vertigo Treatment Market

• 18.1. France Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vertigo Treatment Market

• 19.1. Italy Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vertigo Treatment Market

• 20.1. Spain Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vertigo Treatment Market

• 21.1. Eastern Europe Vertigo Treatment Market Overview
• 21.2. Eastern Europe Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vertigo Treatment Market

• 22.1. Russia Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vertigo Treatment Market

• 23.1. North America Vertigo Treatment Market Overview
• 23.2. North America Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vertigo Treatment Market

• 24.1. USA Vertigo Treatment Market Overview
• 24.2. USA Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vertigo Treatment Market

• 25.1. Canada Vertigo Treatment Market Overview
• 25.2. Canada Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vertigo Treatment Market

• 26.1. South America Vertigo Treatment Market Overview
• 26.2. South America Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vertigo Treatment Market

• 27.1. Brazil Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vertigo Treatment Market

• 28.1. Middle East Vertigo Treatment Market Overview
• 28.2. Middle East Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vertigo Treatment Market

• 29.1. Africa Vertigo Treatment Market Overview
• 29.2. Africa Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vertigo Treatment Market Competitive Landscape And Company Profiles

• 30.1. Vertigo Treatment Market Competitive Landscape
• 30.2. Vertigo Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Vertigo Treatment Market Other Major And Innovative Companies

• 31.1. Lupin Ltd.
• 31.2. Vertigenius
• 31.3. Kracie Holdings Ltd.
• 31.4. Biologische Heilmittel Heel GmbH
• 31.5. Interacoustics A/S.
• 31.6. AdvaCare Pharma
• 31.7. AuroPharma Inc.
• 31.8. Biofield Pharma Pvt Ltd.
• 31.9. Sound Pharmaceuticals Inc.
• 31.10. Otolith Labs Inc.
• 31.11. Ear Technology Corporation
• 31.12. NeuroEquilibrium Diagnostic Systems Pvt Ltd.
• 31.13. Vestibular First
• 31.14. Natus Medical Incorporated
• 31.15. Ronish Bioceuticals

32. Global Vertigo Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vertigo Treatment Market

34. Recent Developments In The Vertigo Treatment Market

35. Vertigo Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Vertigo Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vertigo Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vertigo Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer